SCHEMBL13285355

SCHEMBL13285355

CN1C(=O)c2ccc3c4c(ccc(c24)C1=O)C(=O)OC3=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 5/20 0.50
▸ KMT2A Q03164 5/20 0.50
▸ ALDH1A1 P00352 4/20 0.50
▸ USP2 O75604 2/20 0.50
▸ KEAP1 Q14145 2/20 0.50
▸ NFE2L2 Q16236 2/20 0.50
▸ HPGD P15428 2/20 0.50
▸ ATM Q13315 1/20 0.50
▸ KDM4E B2RXH2 1/20 0.50
▸ POLB P06746 1/20 0.47
▸ PRMT1 Q99873 1/20 0.47
▸ CASP3 P42574 1/20 0.47
▸ TYMS P04818 3/20 0.45
▸ ALOX15 P16050 2/20 0.42
▸ TDP1 Q9NUW8 1/20 0.42
▸ L3MBTL1 Q9Y468 3/20 0.42
▸ MAPT P10636 2/20 0.42
▸ HSD17B10 Q99714 2/20 0.42
▸ MAPK1 P28482 1/20 0.42
▸ TERT O14746 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12672639 0.92 MEN1 (0.49) MEN1KMT2AALDH1A1USP2KEAP1
SCHEMBL13009250 0.92 MEN1 (0.49) MEN1KMT2AALDH1A1USP2KEAP1
SCHEMBL127059 0.86 MEN1 (0.55) MEN1KMT2AALDH1A1USP2KEAP1
SCHEMBL30937815 0.86 MEN1 (0.55) MEN1KMT2AALDH1A1USP2KEAP1
SCHEMBL148025 0.81 TYMS (0.62) MEN1KMT2AALDH1A1HPGDKDM4E
SCHEMBL13285362 0.79 MEN1 (0.50) MEN1KMT2AALDH1A1USP2KEAP1
SCHEMBL17775318 0.79 TERT (0.51) MEN1KMT2AALDH1A1USP2ATM
SCHEMBL710594 0.77 TERT (0.56) MEN1KMT2AALDH1A1USP2KEAP1
SCHEMBL12170761 0.77 TERT (0.56) MEN1KMT2AALDH1A1USP2KEAP1
SCHEMBL9968958 0.77 TERT (0.56) MEN1KMT2AALDH1A1USP2KEAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3415989-B1 ELECTROPHOTOGRAPHIC PHOTOSENSITIVE MEMBER, PROCESS CARTRIDGE, AND IMAGE FORMING APPARATUS KYOCERA DOCUMENT SOLUTIONS INC (JP) 2020-07-22 — — EP disclosed
US-20150179714-A1 Crosslinkable, /Polymerizable and Combinations Thereof Charge-transporting Molecular Glass Mixtures, Luminescent Molecular Glass Mixtures, or Combinations Thereof for Organic Light Emitting Diodes and other Organic Electronics and Photonics Applications and Mothod of Making Same. Molaire Consulting 2015-06-25 — — US disclosed
US-7763727-B2 Compound and organic electronic device using the same MITSUI CHEMICALS, INC. (JP) 2010-07-27 — — US disclosed
US-20070219375-A1 Novel Compound and Organic Electronic Device Using the Same MITSUI CHEMICALS, INC. (JP) 2007-09-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070219375-A1 Novel Compound and Organic Electronic Device Using the Same OR10J3, RPS10, NOX4 MEN1 2327/4885KMT2A 2073/4885ALDH1A1 1416/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback